Xi Jiahui, Zheng Wei, Chen Min, Zou Qingjian, Tang Chengcheng, Zhou Xiaoqing
Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, South China Institute of Large Animal Models for Biomedicine, School of Biotechnology and Health Science, Wuyi University, Jiangmen, China.
Front Cell Dev Biol. 2023 Jan 12;10:1093534. doi: 10.3389/fcell.2022.1093534. eCollection 2022.
The shortage of donor resources has greatly limited the application of clinical xenotransplantation. As such, genetically engineered pigs are expected to be an ideal organ source for xenotransplantation. Most current studies mainly focus on genetically modifying organs or tissues from donor pigs to reduce or prevent attack by the human immune system. Another potential organ source is interspecies chimeras. In this paper, we reviewed the progress of the genetically engineered pigs from the view of immunologic barriers and strategies, and discussed the possibility and challenges of the interspecies chimeras.
供体资源的短缺极大地限制了临床异种移植的应用。因此,基因工程猪有望成为异种移植的理想器官来源。目前大多数研究主要集中在对供体猪的器官或组织进行基因改造,以减少或防止人类免疫系统的攻击。另一种潜在的器官来源是种间嵌合体。在本文中,我们从免疫屏障和策略的角度综述了基因工程猪的研究进展,并讨论了种间嵌合体的可能性和挑战。